Table 6.

Prevalence rates of memory-related SCS subtypes in relation to the presence/absence of physical comorbidity (n=8,036)

Physical comorbidity		Prevalence of mr SCS without concerns1 (%)	Prevalence of mr SCS with some concerncs1 (%)	Prevalence of mr SCS with strong concerncs1 (%)	χ²	df	p value
Arterial hypertension	Yes	26.3	23.5	3.2	0.876	3	0.831
	No	26.2	42.2	3.4
Hyperlipidemia	Yes	25.9	23.4	3.9	5.076	3	0.166
	No	26.4	24.2	3.0
Thyroid disease	Yes	27.2	24.9	3.0	5.127	3	0.163
	No	25.9	23.5	3.4
Cardiac arrhythmia	Yes	27.2	24.8	3.0	1.546	3	0.672
	No	26.2	23.8	3.4
Diabetes mellitus	Yes	25.7	24.6	2.6	1.817	3	0.611
	No	26.3	23.8	3.4
Any cancer	Yes	24.6	24.2	3.9	2.271	3	0.518
	No	26.5	23.9	3.2
Coronary heart disease/angina pectoris	Yes	30.4	22.4	3.2	2.273	3	0.518
	No	26.1	23.9	3.3
Myocardial infarction	Yes	27.5	27.5	4.5	3.329	3	0.344
	No	26.3	23.8	3.3
Stroke	Yes	16.3	29.5	5.4	11.185	3	0.011
	No	26.5	23.8	3.3
Cardiac insufficiency	Yes	30.2	22.0	1.3	3.249	3	0.355
	No	26.2	23.9	3.4
Epilepsy	Yes	19.7	26.5	1.7	4.040	3	0.257
	No	26.4	23.8	3.3
Peripheral artery occlusive disease/ intermittent claudication	Yes	28.8	21.3	1.3	1.546	3	0.672
	No	26.3	23.9	3.3
Parkinson’s disease	Yes	20.8	29.2	4.2	0.608	3	0.895
	No	26.3	23.9	3.3
Multiple sclerosis	Yes	29.6	18.5	3.7	0.469	3	0.926
	No	26.3	23.9	3.3

¹For calculation of the prevalence rates, weights were used which corrected for sample deviations in distribution from the adult population structure of the city of Leipzig in 2012 with regard to age and sex

df degree of freedom, mr memory-related, SCS subjective cognitive symptoms